GSPQX
Price
$20.44
Change
+$0.07 (+0.34%)
Updated
Aug 21 closing price
Net Assets
3.94B
KNGLX
Price
$11.83
Change
+$0.06 (+0.51%)
Updated
Aug 21 closing price
Net Assets
48.67M
Interact to see
Advertisement

GSPQX vs KNGLX

GSPQX vs KNGLX Comparison Chart in %
View a ticker or compare two or three
VS
GSPQX vs. KNGLX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSPQX is a StrongBuy and KNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSPQX has more cash in the bank: 3.94B vs. KNGLX (48.7M). KNGLX pays higher dividends than GSPQX: KNGLX (1.42) vs GSPQX (0.06). GSPQX was incepted earlier than KNGLX: GSPQX (21 years) vs KNGLX (9 years). GSPQX (1.86) is less costly to investors than KNGLX (1.70). KNGLX is a more actively managed with annual turnover of: 422.70 vs. GSPQX (29.00). GSPQX (1000) and KNGLX (1000) have matching initial minimum investment requirements. GSPQX annual gain was more profitable for investors over the last year : 13.89 vs. KNGLX (1.65). GSPQX return over 5 years is better than : 27.70 vs. KNGLX (-9.45).
GSPQXKNGLXGSPQX / KNGLX
Total Expense Ratio1.751.20146%
Annual Report Gross Expense Ratio1.861.70109%
Fund Existence21 years9 years-
Gain YTD12.6513.115406%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets3.94B48.7M8,086%
Annual Yield % from dividends0.061.425%
Returns for 1 year13.891.65843%
Returns for 3 years39.77-4.11-967%
Returns for 5 years27.70-9.45-293%
Returns for 10 years75.02N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USIO2.810.15
+5.64%
Usio
PRLD6.630.13
+2.00%
Prelude Therapeutics
PMAX1.260.02
+1.61%
Powell Max Limited
BWXT156.780.34
+0.22%
BWX Technologies
SUPN45.85-1.60
-3.37%
Supernus Pharmaceuticals